Buy Anti-Allergy Medicine Online to Cure Symptoms of Seasonal Allergies - Onlinepillmart
Allegra (fexofenadine) is used for treating the symptoms of seasonal allergies (hay fever) in adults and children. Allegra is also used to treat skin itching and hives caused by a condition effect called chronic idiopathic urticaria in adults and children. Allegra may also be used for purposes not listed in this medication guide.
DOSAGE AND ADMINISTRATION
This tablets are available in 30 mg, 60 mg, and 180 mg power. In this tablets are covered with a peach colored film coating. Tablets have the following different shape and identifiers: 30 mg tablets are round, bi-convex and have 03 on one side and a scripted "e" on the other; 60 mg tablets are oval, bi-convex and have 06 on one side and a scripted "e" on the other; and 180 mg tablets are oblong, bi-convex and have 018 on one side and a scripted "e" on the other.
€ Adults and Children 12 Years and more: The given dose of this medicine is 60 mg twice daily or 180 mg once in a day with water.
€ Children 2 to 11 Years: The recommended dose of ALLEGRA (fexofenadine hcl) oral suspension is 30 mg twice daily. A dose of 30 mg (5 mL) once daily is recommended as the starting dose in pediatric patients with decreased renal function
SIDE EFFECTS
Major side effects
€ Hives
€ Difficulty breathing
€ Swelling of your face
€ Lips, tongue, or throat
Then stop taking fexofenadine and call your Doctor.
Minor side effects may include:
€ Nausea, Diarrhea, Upset stomach
€ Menstrual cramps
€ Drowsiness, Tired feeling
€ Headache
€ Muscle or Back pain.
PRECAUTIONS
In Specific Populations
I. Pregnancy: There are no adequate and well specific studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
II. Pediatric Use: The given doses of this medicine in pediatric patients 6 months to 11 years of old are based on cross-study comparison of the pharmacokinetics of fexofenadine in adults and pediatric subjects and on the safety profile of this is in both adult and pediatric subjects at doses equal to or higher than the recommended doses. The effectiveness of ALLEGRA (fexofenadine hydrochloride) in pediatric patients under 6 months of age has not been established.
OVERDOSE:
Faintness, sleepiness, and dry mouth have been reported with ALLEGRA (fexofenadine hydrochloride) overdose. Single doses of this is up to 800 mg (6 healthy subjects at this dose level), and doses up to 690 mg two times in a day for 1 month (3 healthy subjects at this dose level) or 240 mg once daily for 1 year (234 healthy subjects at this dose level) were administered without the development of clinically significant adverse events as compared to placebo.
DOSAGE AND ADMINISTRATION
This tablets are available in 30 mg, 60 mg, and 180 mg power. In this tablets are covered with a peach colored film coating. Tablets have the following different shape and identifiers: 30 mg tablets are round, bi-convex and have 03 on one side and a scripted "e" on the other; 60 mg tablets are oval, bi-convex and have 06 on one side and a scripted "e" on the other; and 180 mg tablets are oblong, bi-convex and have 018 on one side and a scripted "e" on the other.
€ Adults and Children 12 Years and more: The given dose of this medicine is 60 mg twice daily or 180 mg once in a day with water.
€ Children 2 to 11 Years: The recommended dose of ALLEGRA (fexofenadine hcl) oral suspension is 30 mg twice daily. A dose of 30 mg (5 mL) once daily is recommended as the starting dose in pediatric patients with decreased renal function
SIDE EFFECTS
Major side effects
€ Hives
€ Difficulty breathing
€ Swelling of your face
€ Lips, tongue, or throat
Then stop taking fexofenadine and call your Doctor.
Minor side effects may include:
€ Nausea, Diarrhea, Upset stomach
€ Menstrual cramps
€ Drowsiness, Tired feeling
€ Headache
€ Muscle or Back pain.
PRECAUTIONS
In Specific Populations
I. Pregnancy: There are no adequate and well specific studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
II. Pediatric Use: The given doses of this medicine in pediatric patients 6 months to 11 years of old are based on cross-study comparison of the pharmacokinetics of fexofenadine in adults and pediatric subjects and on the safety profile of this is in both adult and pediatric subjects at doses equal to or higher than the recommended doses. The effectiveness of ALLEGRA (fexofenadine hydrochloride) in pediatric patients under 6 months of age has not been established.
OVERDOSE:
Faintness, sleepiness, and dry mouth have been reported with ALLEGRA (fexofenadine hydrochloride) overdose. Single doses of this is up to 800 mg (6 healthy subjects at this dose level), and doses up to 690 mg two times in a day for 1 month (3 healthy subjects at this dose level) or 240 mg once daily for 1 year (234 healthy subjects at this dose level) were administered without the development of clinically significant adverse events as compared to placebo.